iBio Cash Flow per Share
The Operating Cash Flow per Share of iBio (IBIO) as of Oct 8, 2026 is -0.22 USD. In the previous year, Operating Cash Flow per Share was -0.15 USD — a change of 44.53% (lower).
Get this data via API
Financial Data API
Cash Flow per Share
-0.22USD
YoY
44.53%
Last updated:
Operating Cash Flow per Share of iBio is 2026 -0.22 USD. Operating Cash Flow per Share of iBio was 2025 -0.15 USD. It decreases by 44.53% lower compared to the previous year.
The iBio Cash Flow per Share history
3 Years
10 Years
25 Years
Max
Cash Flow per Share
Date
Cash Flow per Share
Jan 1, 2019
-189.36 USD
Jan 1, 2020
-35.47 USD
Jan 1, 2021
-68.95 USD
Jan 1, 2022
-77.08 USD
Jan 1, 2023
-16.40 USD
Jan 1, 2024
-2.03 USD
Jan 1, 2025
-0.15 USD
Jan 1, 2026
-0.22 USD
| YEAR | Cash Flow per Share | YoY |
|---|---|---|
| -0.22USD | +44.53% | |
| -0.15USD | -92.40% | |
| -2.03USD | -87.61% | |
| -16.40USD | -78.73% | |
| -77.08USD | +11.79% | |
| -68.95USD | +94.38% | |
| -35.47USD | -81.27% | |
| -189.36USD | -47.46% | |
| -360.43USD | -47.15% | |
| -682.02USD | +50.40% | |
| -453.48USD | +5,837.03% | |
| -7.64USD | +5.35% | |
| -7.25USD | — |
Access this data via the Eulerpool API
iBio Stock analysis
What does iBio do? iBio is one of the most popular companies on Eulerpool.
Frequently Asked Questions about iBio stock
Operating Cash Flow per Share of iBio is -0.22 USD in 2026.
Operating Cash Flow per Share of iBio changed from -0.15 USD to -0.22 USD, representing a 44.53% change. The value is lower than the previous year.
On Eulerpool you can find the complete historical development of Operating Cash Flow per Share iBio since 2006 – with annual values, charts, and detailed analysis.
Operating cash flow per share measures the operating cash generated per outstanding share.
Access this data via the Eulerpool API
Cash Flow — iBio
Operating Cash FlowCapital ExpendituresFree Cash FlowFCF per ShareDividends PaidShare BuybacksInvesting Cash FlowFinancing Cash FlowCapEx / RevenueCash Flow per ShareStock-Based CompensationChange in Working CapitalAcquisitions (Net)Net Change in CashCapEx/OCFFCF/Net IncomeFCF ConversionCash ConversionTotal Shareholder PayoutCapEx/D&A
All Key Metrics — iBio
Valuation
Income Statement
Margins
Balance Sheet
- Total Assets
- Current Assets
- Cash & Equivalents
- Receivables
- Inventory
- Property, Plant & Equipment
- Goodwill
- Intangible Assets
- Equity
- Liabilities
- Debt
- Current Liabilities
- Long-term Debt
- Short-term Debt
- Retained Earnings
- Book Value per Share
- Tangible Book Value per Share
- Working Capital
- Investments
- Accounts Payable
- Non-Current Assets
- Short-Term Investments
- Long-Term Investments
- Net Debt
- Treasury Stock
- Minority Interest
- Deferred Tax Liabilities
- Net Tangible Assets
- Goodwill/Assets
- Intangibles/Assets
Cash Flow
- Operating Cash Flow
- Capital Expenditures
- Free Cash Flow
- FCF per Share
- Dividends Paid
- Share Buybacks
- Investing Cash Flow
- Financing Cash Flow
- CapEx / Revenue
- Cash Flow per Share
- Stock-Based Compensation
- Change in Working Capital
- Acquisitions (Net)
- Net Change in Cash
- CapEx/OCF
- FCF/Net Income
- FCF Conversion
- Cash Conversion
- Total Shareholder Payout
- CapEx/D&A
Profitability
- ROE
- ROA
- ROCE
- ROIC
- Asset Turnover
- Inventory Turnover
- Receivables Turnover
- Days Sales Outstanding
- Days Inventory Outstanding
- Days Payable Outstanding
- Cash Conversion Cycle
- CROIC
- Gross Profit/Assets
- Fixed Asset Turnover
- Equity Turnover
- Working Capital Turnover
- Payables Turnover
- Capital Intensity
- Receivables/Revenue
- Inventory/Revenue
- EBIT/Assets
Leverage
Growth
- Revenue Growth
- Revenue CAGR 3Y
- Revenue CAGR 5Y
- Revenue CAGR 10Y
- Earnings Growth
- EPS Growth
- EBIT Growth
- EBIT CAGR 3Y
- EBIT CAGR 5Y
- EBIT CAGR 10Y
- Dividend Growth
- FCF Growth
- Book Value Growth
- Earnings CAGR 3Y
- Earnings CAGR 5Y
- Earnings CAGR 10Y
- EPS CAGR 3Y
- EPS CAGR 5Y
- EBITDA Growth YoY
- EBITDA CAGR 3Y
- EBITDA CAGR 5Y
- Gross Profit Growth
- OCF Growth YoY
- Employee Growth
- Dividend CAGR 3Y
- Dividend CAGR 5Y
- Dividend CAGR 10Y
- Asset Growth
- Equity Growth
- Debt Growth
- CapEx Growth
- FCF CAGR 3Y
- FCF CAGR 5Y
- Market Cap Growth
- Share Count Growth